Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Intracellular spread protein IcsA, also known as VirG, is a 120 kDa outer membrane autotransporter protein primarily found in Shigella species, such as Shigella flexneri [1, 2]. It plays a pivotal role in bacterial pathogenesis by mediating actin-based motility, which allows the pathogen to move within the host cell cytoplasm and spread to adjacent cells [3, 5]. IcsA achieves this by polarly localizing on the bacterial surface and recruiting host cell factors, specifically neural Wiskott-Aldrich syndrome protein (N-WASP) and the Arp2/3 complex, to trigger actin polymerization [3, 12]. This process forms actin comet tails that propel the bacteria, facilitating the formation of protrusions and subsequent infection of neighboring cells [8, 13]. Additionally, IcsA functions as an adhesin and is involved in biofilm formation and the evasion of host autophagy by interacting with proteins like IcsB and Atg5 [1, 4, 7]. Because it is essential for virulence and conserved across various serotypes, IcsA is a major target for the development of vaccines, such as multiepitope fusion antigens (MEFA), and anti-virulence therapies aimed at disrupting bacterial dissemination [4, 11]. Experimental inhibitors like A22 and MP265 have been shown to disrupt its polar localization, highlighting its potential as a therapeutic target [6, 9].
Inhibition of polar localization, blocking of N-WASP recruitment, or induction of neutralizing antibodies to prevent bacterial adhesion and spread.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Intracellular spread protein IcsA (IcsA).